These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14562111)

  • 1. Expression of FLIP(Long) and FLIP(Short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis.
    Benesch M; Platzbecker U; Ward J; Deeg HJ; Leisenring W
    Leukemia; 2003 Dec; 17(12):2460-6. PubMed ID: 14562111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
    de Melo Campos P; Traina F; da Silva Santos Duarte A; Lorand-Metze I; Costa FF; Saad ST
    Leuk Res; 2007 Jun; 31(6):853-7. PubMed ID: 17270269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
    Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
    Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.
    Kim H; Whartenby KA; Georgantas RW; Wingard J; Civin CI
    Stem Cells; 2002; 20(2):174-82. PubMed ID: 11897874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
    Fulda S; Meyer E; Debatin KM
    Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs).
    Kerbauy DM; Lesnikov V; Abbasi N; Seal S; Scott B; Deeg HJ
    Blood; 2005 Dec; 106(12):3917-25. PubMed ID: 16105982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cellular FLICE-inhibitory protein (FLIP) in gastric adenocarcinoma.
    Zhou XD; Yu JP; Liu J; Luo HS; Chen HX; Yu HG
    Clin Sci (Lond); 2004 Apr; 106(4):397-405. PubMed ID: 14636156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI; Bolaraki PE; Voulgarelis M
    Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [STAT5 phosphorylation in CD34(+)CD38(-)CD123(+) bone marrow cells of the patients with myelodysplastic syndrome].
    Liu BN; Fu R; Wang HQ; Li LJ; Yue LZ; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Wu YH; Song J; Xing LM; Guan J; Wang J; Shao ZH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):480-3. PubMed ID: 22967386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes].
    Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows.
    Mundle S; Venugopal P; Shetty V; Ali A; Chopra H; Handa H; Rose S; Mativi BY; Gregory SA; Preisler HD; Raza A
    Int J Hematol; 1999 Apr; 69(3):152-9. PubMed ID: 10222652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer.
    Zhang X; Jin TG; Yang H; DeWolf WC; Khosravi-Far R; Olumi AF
    Cancer Res; 2004 Oct; 64(19):7086-91. PubMed ID: 15466204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules.
    Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
    Arthritis Rheum; 2000 May; 43(5):1106-14. PubMed ID: 10817565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
    Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of death receptor signals by cellular FLIP.
    Irmler M; Thome M; Hahne M; Schneider P; Hofmann K; Steiner V; Bodmer JL; Schröter M; Burns K; Mattmann C; Rimoldi D; French LE; Tschopp J
    Nature; 1997 Jul; 388(6638):190-5. PubMed ID: 9217161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP.
    Wang J; Lobito AA; Shen F; Hornung F; Winoto A; Lenardo MJ
    Eur J Immunol; 2000 Jan; 30(1):155-63. PubMed ID: 10602037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
    Zhang Z; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes.
    Boudard D; Vasselon C; Berthéas MF; Jaubert J; Mounier C; Reynaud J; Viallet A; Chautard S; Guyotat D; Campos L
    Am J Hematol; 2002 Jun; 70(2):115-25. PubMed ID: 12111784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.